Replies to post #109349 on Biotech Values

[xray72]

The phIII trial will include 360 patients. If results from this trial are positive they will get market approval...so chances are they will IPO following market approval.

I would much more prefer to hold stocks in this company than in Dendreon or other peers...will see.